South Wales, Aug. 23 -- United Kingdom Intellectual Property Office (UKIPO) has registered trademark "Sypher" on July 3. The details about the trademark application no. UK00004228762 published in the journal no. 2025/034 (Aug. 22).
With Freeths LLP as representative, SYNGENSYS LIMITED filed the trademark application for the below mentioned good(s)/service(s).
Class 9 : Computer software and mobile application software for collection of information, particularly commercial, scientific, health, gene and cell information; computer software and mobile application software for collection of data, particularly commercial, scientific, health, gene and cell data; computer software and mobile application software for access to databases, computerized files and records relating to the health status of individuals, molecules and formulation for medical use, as well as medicines and medical research; computer software and mobile application software for collating and maintaining computer files and data in electronic format; computer software and mobile application software for the bringing together, for third parties, of service offers relating to capture, collection, analysis, processing and use of data, particularly medical, health gene and cell research data; computer software and mobile application software for data capture, collection, analysis, processing and use of data, particularly health, gene and cell data; computer software and mobile application software for compilation of scientific and technical information, of information related to people's health, to medicines [medical information] and to gene and cell therapy; computer software and mobile application software for compilation of medical reports, medical prescriptions and recommendations [medical information].
Class 42 : Structural and functional analysis of genomes; genetic fingerprinting; genetic research; research in the field of gene therapy; laboratory research in the field of gene expression; analysis in the field of molecular biology; biochemical analysis; structural and functional analysis of genomes; research and development services in the field of gene expression systems; research and development services in the field of genes and cells; biotechnology research; scientific research in the field of genetics and genetic engineering; biological analysis; genetic mapping for scientific purposes; genetic engineering services; biotechnology testing; biochemical research and development; scientific and technical analysis and research; computer testing and analysis; quality control and auditing; quality control of software, scientific and technical data and scientific and technical analyses; design of technical and scientific studies; design, development, programming, configuration, installation, maintenance, updating and testing of algorithms and software, particularly for artificial intelligence and decision support systems; design, development, programming, configuration, installation, maintenance, updating and testing of algorithms and computer software and platforms for consulting, analyzing, exchanging and sharing data, particularly in a collaborative work environment; design, development, formulation, updating and testing of new medicines and new medicine formulas [scientific research]; evaluation of the performance of medical treatments [quality control]; design, development, selection, training and remote provision [SaaS] of models and software for gene and cell therapy; software as a service [SaaS]; platforms for gene and cell therapy research as SaaS [Software as a Service]; software as a service [SaaS] for data input, extraction, processing, display and storage relating to gene and cell therapy; sofware as a service [SaaS] for collection of information, particularly commercial, scientific, health, gene and cell information; sofware as a service [SaaS] for collection of data, particularly commercial, scientific, health, gene and cell data; sofware as a service [SaaS] for access to databases, computerized files and records relating to the health status of individuals, molecules and formulation for medical use, as well as medicines and medical research; sofware as a service [SaaS] for collating and maintaining computer files and data in electronic format; sofware as a service [SaaS] for the bringing together, for third parties, of service offers relating to capture, collection, analysis, processing and use of data, particularly medical, health gene and cell research data; sofware as a service [SaaS] for data capture, collection, analysis, processing and use of data, particularly health, gene and cell data; sofware as a service [SaaS] for compilation of scientific and technical information, of information related to people's health, to medicines [medical information] and to gene and cell therapy; sofware as a service [SaaS] for compilation of medical reports, medical prescriptions and recommendations [medical information]; provision of information relating to scientific technology; platform as a service [PaaS] for collection of information, particularly commercial, scientific, health, gene and cell information; platform as a service [PaaS] for collection of data, particularly commercial, scientific, health, gene and cell data; platform as a service [PaaS] for access to databases, computerized files and records relating to the health status of individuals, molecules and formulation for medical use, as well as medicines and medical research; platform as a service [PaaS] for collating and maintaining computer files and data in electronic format; platform as a service [PaaS] for the bringing together, for third parties, of service offers relating to capture, collection, analysis, processing and use of data, particularly medical, health gene and cell research data; platform as a service [PaaS] for data capture, collection, analysis, processing and use of data, particularly health, gene and cell data; platform as a service [PaaS] for compilation of scientific and technical information, of information related to people's health, to medicines [medical information] and to gene and cell therapy; platform as a service [PaaS] for compilation of medical reports, medical prescriptions and recommendations [medical information].provision of temporary use of non-downloadable software for data processing and analysis relating to gene and cell therapy; preparation of technical and scientific manuals; preparation of technical and scientific reports; technology research; scientific research services; data analysis computer services; computer services for data analysis and interpretation relating to gene and cell therapy; information and advice concerning all the aforesaid services; all the aforesaid services provided in connection with or relating to scientific research and the medical field; research in the field of gene therapy; stem cell research services; stem cell research; advisory services relating to gene therapy research; research and development services in the field of gene expression systems; cell separation technology services; cell separation research services; laboratory research in the field of gene expression; biotechnology research for determining the neuronal survival of molecules in animal models; biological cloning services; research and development of vaccines and medicines; advisory services relating to gene therapy research; laboratory services relating to the production of monoclonal antibodies; biotechnology research; research in the field of cell therapy.
Class 44 : Medical analysis for diagnosis and treatment of persons; medical, gene and cell data analysis; conducting of studies and analyses on health of persons, medicines for medical diagnostic and treatment purposes and for gene and cell therapy; medical screening; preparation of medical reports and medical recommendations; carrying out disease diagnostics; advisory services in the field of health care, gene and cell therapy; medical diagnosis services; stem cell therapy services; stem cell storage; stem cell bank services; cultured cell bank services for medical transplantation; medical treatment using cultured cells; RNA or DNA analysis for cancer diagnosis and prognosis; medical services relating to the removal, treatment and processing of human genes and cells; information and advice concerning all the aforesaid services.
The original document can be viewed at: http://www.ipo.gov.uk/cgi-bin/redirect.cgi?type=tmj&link=6¶m1=UK00004228762
Disclaimer: Curated by HT Syndication.
